Natural surfactant combined with beclomethasone decreases oxidative lung injury in the preterm lamb

Pediatric Pulmonology

Volumn 44, Issue 12, 2009, Pages 1159-1167

  Dani, Carlo ^a   Corsini, Iuri ^a   Burchielli, Silvia ^b   Cangiamila, Valentina ^c   Longini, Mariangela ^d   Paternostro, Ferdinando ^e   Buonocore, Giuseppe ^d   Rubaltelli, Firmino F ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Glucocorticoids; Oxidative stress; Preterm lamb; Respiratory distress syndrome; Surfactant

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; BECLOMETASONE; HYDROPEROXIDE; SURFACTANT;

AIRWAY PRESSURE; AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GAS ANALYSIS; BRONCHIAL ASPIRATION PROCEDURE; CELL COUNT; CONTROLLED STUDY; FEMALE; GAS EXCHANGE; LAMB; LUNG COMPLIANCE; LUNG INJURY; LUNG LAVAGE; LUNG MECHANICS; LUNG PARENCHYMA; MEAN ARTERIAL PRESSURE; MICROPHOTOGRAPHY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; TIDAL VOLUME;

ANIMALS; BECLOMETHASONE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; OXIDATIVE STRESS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SHEEP; TREATMENT OUTCOME;

EID: 73449145336     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21145     Document Type: Article

References (37)

1. Saugstad OD. Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD? Acta Paediatr 1997;86:1277-1282.
2. Saugstad OD. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 2003;8:39-49.
3. Ogden B, Murphy SA, Saunders G, Pathak D, Johnson D. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 1984;130:817-821.
4. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994;93:712-718.
5. Horowitz S, Shapiro DL, Finkelstein JN, Notter RH, Johnston CJ, Quible DJ. Changes in gene expression in hyperoxia induced neonatal lung injury. Am J Physiol 1990;258:L107-L111.
6. Schock BC, Sweet DG, Ennis M, Warner JA, Young IS, Halliday HL. Oxidative stress and increased type-IV collagenase levels in bronchoalveolar lavage fluid from newborn babies. Pediatr Res 2001;50:29-33.
7. Holm BA, Matalon S, Finkelstein JN, Notter RH. Type II pneumocyte changes during hyperoxic lung injury and recovery. J Appl Physiol 1988;65:2672-2678.
8. Haagsman HP. Oxidative damage of the pulmonary surfactant system. Semin Neonatol 1998;3:207-217.
9. Nogee LM, Wispe JR, Clark JC, Weaver T, Whitsett JA. Increased expression of pulmonary surfactant proteins in oxygen exposed rats. Am J Respir Cell Mol Biol 1991;4:102-107.
10. Hallman M. Molecular interactions between nitric oxide and lung surfactant. Biol Neonate 1997;71:44-48.
11. Finck CM, Hodell MG, Marx WH, Paskanik AM, McGraw DJ, Lutz CJ, Gatto LA, Picone AL, Nieman GF. Endotoxin-stimulated alveolar macrophage recruitment of neutrophils and modulation with exogenous surfactant. Crit Care Med 1998;26: 1414-1418.
12. Miles PR, Bowman L, Rao KM, Baatz JE, Huffman L. Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages. Am J Physiol 1999;276:L186-L196.
13. Hayakawa H, Giridhar G, Myrvik QN, Kucera L. Pulmonary surfactant phospholipids modulate priming of rabbit alveolar macrophages for oxidative responses. J Leukoc Biol 1992;51: 379-385.
14. Kerecman J, Mustafa SB, Vasquez MM, Dixon PS, Castro R. Immunosuppressive properties of surfactant in alveolar macrophage NR8383. Inflamm Res 2008;57:118-125.
15. Sadowska AM, Klebe B, Germonpre P, De Backer WA. Glucocorticosteroids as antioxidants in treatment of asthma and COPD New application for an old medication? Steroids 2007;72: 1-6.
16. Frank L, Lewis PL, Sosenko IR. Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics 1985;75:569-574.
17. Walther FJ, David-Cu R, Mehta EI, Polk DH, Jobe AH, Ikegami M. Higher lung antioxidant enzyme activity persists after single dose of corticosteroids in preterm lambs. Am J Physiol 1996;271: L187-L191.
18. Chandrasekar I, Eis A, Konduri GG. Betamethasone attenuates oxidant stress in endothelial cells from fetal lambs with persistent pulmonary hypertension. Pediatr Res 2008;63:67-72.
19. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK 3rd, Gluck L. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 1983; 72:656-656.
20. Yeh TF, Lin HC, Chang CH, Wu TS, Su BH, Li TC, Pyati S, Tsai CH. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. Pediatrics 2008;121:e1310-e1318.
21. Buonocore G, Perrone S, Longini M, Terzuoli L, Bracci R. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr Res 2000;47:221-224.
22. Witko-Sarsat V, Freidlander M, Capeillere-Blandin C, Nguyen-Khoa T, Thu Nguyen A, Zingraff J, Jungers P, Descamps-Latsca B. Advanced oxidation protein product as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-1313.
23. Kime R, Gibson A, Yong W, Hider R, Powers H. Chromatographic method for the determination of non-transferrin-bound iron suitable for use on the plasma and bronchoalveolar lavage fluid of preterm babies. Clin Sci 1996;91:633-638.
24. de Blic J, Midulla F, Barbato A, Clement A, Dab I, Eber E, Green C, Grigg J, Kotecha S, Kurland G, et al. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European respiratory Society. Eur Respir J 2000;15: 217-231.
25. Dani C, Martelli E, Bertini G, Pezzati M, Rossetti M, Buonocore G, Paffetti P, Rubaltelli FF. Effect of blood transfusions on oxidative stress in preterm infants. Arch Dis Child Fetal Neonatal Ed 2004;89:F408-F411.
26. Signorini C, Perrone S, Sgherri C, Ciccoli L, Buonocore G, Leoncini S, Rossi V, Vecchio D, Comporti M. Plasma esterified F2-isoprostanes and oxidative stress in newborns: role of nonprotein-bound iron. Pediatr Res 2008;63:287-291.
27. van Beurden WJC, Harff GA, Dekhuijzen PNR, van der Poel-Smet SM, Smeenk FWJM. Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients. Respiration 2003;70:242-248.
28. Mokra D, Mokry J, Drgova A, Petraskova M, Bulokova J, Calkosvka A. Intratracheally administered corticosteroids improve lung function in meconium-instilled rabbits. J Physiol Pharmacol 2007;58:389-398.
29. Wang J, Winskog C, Edston E, Walther SM. Inhaled and intravenous corticosteroids both attenuate chlorine gas-induced lung injury in pigs. Acta Anaesthesiol Scand 2005;49:183-190.
30. LaForce WR, Brudno DS. Controlled trial of beclomethasone dipropionate by nebulization in oxygen- and ventilator-dependent infants. J Pediatr 1993;122:285-288.
31. Fanelli A, Maggi E, Stendardi L, Gorini M, Duranti R, Scano G. Preventive effects of beclomethasone on histamine-induced changes in breathing pattern in asthma. Chest 1993;103:122-128.
32. Chen CM, Fang CL, Chang CH. Surfactant and corticosteroid effects on lung function in a rat model of acute lung injury. Crit Care Med 2001;29:2169-2175.
33. American Academy of Pediatrics, Committee on Fetus and Newborn, Canadian Paediatric Society, Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002;109:330-338.
34. Shah SS, Ohlsson A, Halliday H, Shah VS. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight neonates. Cochrane Database Syst Rev 2007;17: CD002057.
35. Nimmo AJ, Carstairs JR, Patole SK, Whitehall J, Davidson K, Vink R. Intratracheal administration of glucocorticoids using surfactant as a vehicle. Clin Exper Pharmcol Physiology 2002;29: 661-665.
36. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy 2008;63:1292-1300.
37. Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Health Technol Assess 2008;12:1-174.